Trends in Molecular Testing of Lung Cancer in Mainland People’s Republic of China Over the Decade 2010 to 2019

INTRODUCTION: Lung cancer is the leading cause of cancer-related morbidity and mortality in the People’s Republic of China. Targeted therapies for patients with lung cancer, which depend on accurate identification of actionable genomic alteration, have improved survival compared with previously avai...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenbin, Lyu, Yunfeng, Wang, Shaoming, Zhou, Xiaoyan, Ma, Jie, Xu, Chao, Fang, Li, Ying, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474368/
https://www.ncbi.nlm.nih.gov/pubmed/34590013
http://dx.doi.org/10.1016/j.jtocrr.2021.100163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474368/
https://www.ncbi.nlm.nih.gov/pubmed/34590013
http://dx.doi.org/10.1016/j.jtocrr.2021.100163

Ejemplares similares